Matthew Leoni

机构：Massachusetts Eye Research and Surgery Institute

发表论文 32 篇 · 总被引 1288 次 · h-index 15

代表论文

• Once-daily topical brimonidine tartrate gel 0·5% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies (2011 · British Journal of Dermatology · 被引 167)
• Reliability of Clinician Erythema Assessment grading scale (2014 · Journal of the American Academy of Dermatology · 被引 138)
• Efficacy and safety of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of two randomized, double-blind, and vehicle-controlled pivotal studies. (2013 · PubMed · 被引 122)
• Emraclidine, a novel positive allosteric modulator of cholinergic M4 receptors, for the treatment of schizophrenia: a two-part, randomised, double-blind, placebo-controlled, phase 1b trial (2022 · The Lancet · 被引 112)
• Long-term safety and efficacy of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of a 1-year open-label study. (2014 · PubMed · 被引 90)
• Rationale and Development of Tavapadon, a D1/D5-Selective Partial Dopamine Agonist for the Treatment of Parkinson’s Disease (2023 · CNS & Neurological Disorders - Drug Targets · 被引 42)